Best Semaglutide Programs: A Physician’s Guide

What separates the best semaglutide weight loss programs from low-quality operators — and how to find a physician-supervised program that meets clinical standards for safety and efficacy.

· DietsMD Editorial Team · 11 min read

Medically Reviewed

Medically reviewed by DietsMD Board-Certified Physicians specializing in obesity medicine and metabolic health. Content is reviewed for clinical accuracy and updated regularly.

Quick Answer

The best semaglutide programs share five qualities: a board-certified physician consultation before prescribing, comprehensive medical intake, licensed U.S. pharmacy fulfillment, transparent all-inclusive pricing, and ongoing physician monitoring with dose titration. Programs that skip any of these steps compromise patient safety.

~15%Avg. body weight lost (STEP-1 trial, 68 weeks)
68%Of STEP-1 participants lost ≥10% body weight
20%Reduction in CV events (SELECT trial)
2021FDA approval for weight loss (Wegovy)

What Is a Semaglutide Program?

A semaglutide program is a physician-supervised treatment plan in which a licensed physician evaluates a patient’s medical history, prescribes semaglutide when clinically appropriate, and provides ongoing monitoring throughout treatment.

Semaglutide (brand name Wegovy® for weight loss, Ozempic® for diabetes) is an FDA-approved GLP-1 receptor agonist that produces an average of approximately 15% body weight loss over 68 weeks in clinical trials. It is administered as a once-weekly subcutaneous injection and requires a physician prescription.

The quality of the program surrounding the prescription — the intake process, physician oversight, pharmacy, monitoring, and support — is what separates the best semaglutide programs from low-quality operators.

Semaglutide requires physician oversight: It is a prescription medication with real contraindications and side effect management requirements. No legitimate program should prescribe semaglutide without a physician consultation and comprehensive medical evaluation.

What the Best Semaglutide Programs Have in Common

1. Board-Certified Physician Consultation

The prescribing physician should hold board certification in obesity medicine, endocrinology, or internal medicine and be licensed in your state. You should be able to identify the physician by name and verify their credentials. A consultation — not just a questionnaire review — should occur before any prescription is issued.

2. Comprehensive Medical Intake

Before prescribing, a quality program collects a detailed health history covering current medications, past medical conditions, family history (particularly thyroid cancer and MEN2), and weight history. This is essential for identifying contraindications and tailoring the treatment plan.

3. Transparent, All-Inclusive Pricing

The best programs are upfront about what is included: consultation fees, medication costs, shipping, and follow-up visits. Hidden fees, surprise charges, or pressure to purchase add-ons are warning signs of a low-quality operator.

4. Licensed U.S. Pharmacy Fulfillment

All medications should be dispensed by a licensed U.S. pharmacy. For compounded semaglutide, the pharmacy should hold 503A or 503B accreditation. Medications sourced from overseas or unverified suppliers are a serious safety risk.

5. Ongoing Monitoring and Dose Titration

Semaglutide is started at 0.25 mg weekly and gradually increased to 2.4 mg over 16–20 weeks. This titration requires physician oversight. The best programs include regular check-ins to monitor weight loss progress, manage side effects, and adjust dosing as needed.

6. Side Effect Management Support

Gastrointestinal side effects — particularly nausea — are common during dose escalation. Quality programs have clear protocols for managing side effects, including dose adjustment guidance and physician access when issues arise.

7. Nutritional and Behavioral Support

Semaglutide is most effective when combined with a reduced-calorie diet and sustainable lifestyle changes. The best programs include nutritional guidance, behavioral coaching, or access to registered dietitians as part of the treatment plan.

8. HIPAA-Compliant Privacy Practices

Your health data is sensitive. Confirm that the telehealth platform is HIPAA-compliant and has clear, enforceable data privacy policies before sharing any medical information.

Green Flags vs. Red Flags

Criteria Green Flag Red Flag
Physician consultation Required before prescribing Not required or unclear
Physician credentials Named, verifiable, board-certified Anonymous or unverifiable
Medical intake Comprehensive, reviewed by physician Minimal or skipped
Pharmacy Licensed U.S. pharmacy (503A/503B) Overseas or unverified
Pricing Transparent, all-inclusive Hidden fees or pressure to buy upfront
Monitoring Regular physician check-ins No follow-up after prescription
Weight loss claims Evidence-based, realistic Guaranteed results
Cancellation policy Clear and fair Vague or punitive

Brand-Name vs. Compounded Semaglutide Programs

Many online semaglutide programs offer compounded semaglutide rather than brand-name Wegovy®. Understanding the difference helps you evaluate what you are being offered.

Brand-Name Wegovy®

  • FDA-approved and manufactured under strict quality controls by Novo Nordisk
  • May be covered by some commercial insurance plans
  • Higher list price; availability has improved significantly since 2024
  • Comes in pre-filled auto-injector pens at specific dose increments

Compounded Semaglutide

  • Prepared by licensed U.S. compounding pharmacies (503A or 503B accredited)
  • Not FDA-approved but legal when prescribed by a licensed physician
  • Typically more cost-accessible than brand-name Wegovy
  • Quality and safety depend on the pharmacy — always confirm accreditation
  • Allows more flexible dosing increments in some cases
Important: The FDA has issued warnings about compounded semaglutide from unaccredited or overseas pharmacies. Always confirm your program uses a licensed, accredited U.S. compounding pharmacy before starting treatment.

How to Evaluate a Semaglutide Program Before Enrolling

  1. Verify the physician. Ask for the name and credentials of the prescribing physician. Confirm they are board-certified and licensed in your state. If the program cannot provide this information, walk away.
  2. Review the intake process. A quality program will ask detailed questions about your medical history, current medications, and family history before the consultation — not after.
  3. Confirm the pharmacy. Ask which pharmacy will fill your prescription and confirm it is a licensed U.S. pharmacy. For compounded semaglutide, ask for the pharmacy’s 503A or 503B accreditation status.
  4. Get a complete price breakdown. Ask what is included in the monthly cost: consultation, medication, shipping, and follow-up visits. Get this in writing before enrolling.
  5. Ask about monitoring. Find out how often you will have physician check-ins, how dose adjustments are handled, and what to do if you experience side effects.
  6. Review the cancellation policy. Understand the terms before committing, especially for programs that require upfront payment for multiple months.
DietsMD Semaglutide Program

How DietsMD Meets Every Standard

  • Physician oversight: Board-certified physicians specializing in obesity medicine conduct every consultation
  • Medical intake: Comprehensive health history reviewed before any prescription is issued
  • Pharmacy: Licensed U.S. pharmacy fulfillment for all medications
  • Pricing: Transparent, all-inclusive pricing with no hidden fees
  • Monitoring: Ongoing physician check-ins, dose titration, and side effect management throughout treatment
  • Privacy: HIPAA-compliant platform with strict data protection
  • Support: Nutritional guidance and behavioral support included
Start your confidential consultation →

Find Out If Semaglutide Is Right for You

DietsMD board-certified physicians evaluate your health history and prescribe semaglutide when clinically appropriate. Transparent pricing. Discreet home delivery. Ongoing support.

Semaglutide vs. Tirzepatide: Which Program Is Right for You?

Both semaglutide and tirzepatide are FDA-approved GLP-1 medications for weight loss available through physician-supervised online programs. Tirzepatide has demonstrated greater average weight loss in clinical trials (~20–22% vs ~15%), but semaglutide has a longer track record and established cardiovascular benefit data from the SELECT trial.

The right choice depends on your health history, cardiovascular risk profile, goals, tolerability, and budget. A board-certified physician is best positioned to make this recommendation based on your individual situation. Read our full comparison: The Complete GLP-1 Weight Loss Guide.

Frequently Asked Questions About Semaglutide Programs

What is the best semaglutide program?

The best semaglutide program is one that requires a board-certified physician consultation before prescribing, conducts a comprehensive medical intake, uses a licensed U.S. pharmacy, provides ongoing monitoring and dose titration, and offers transparent all-inclusive pricing. Programs that skip physician oversight or use unverified pharmacies put patient safety at risk.

How much does a semaglutide program cost per month?

Physician-supervised semaglutide programs typically range from $200 to $500 per month, depending on whether brand-name Wegovy or compounded semaglutide is used and what services are included. Always confirm what is included in the quoted price before enrolling — consultation, medication, shipping, and follow-up visits should all be accounted for.

Is compounded semaglutide safe?

Compounded semaglutide prepared by an accredited U.S. compounding pharmacy (503A or 503B) and prescribed by a licensed physician can be a safe and legitimate option. The FDA has issued warnings about compounded semaglutide from unaccredited or overseas pharmacies. Always confirm your program uses an accredited U.S. compounding pharmacy before starting treatment.

How much weight can I lose with a semaglutide program?

In the STEP-1 clinical trial, participants lost an average of 14.9% of body weight over 68 weeks with semaglutide 2.4 mg weekly. 68% of participants lost 10% or more of body weight. Individual results vary based on starting weight, adherence, diet, activity level, and dose achieved.

Do I need a prescription for semaglutide?

Yes. Semaglutide is a prescription medication in the United States. It cannot be legally obtained without a prescription from a licensed physician. Any program offering semaglutide without a physician consultation and prescription is operating outside the law and should be avoided.

Can I get semaglutide online?

Yes. Licensed telehealth platforms like DietsMD allow patients to consult with board-certified physicians online, receive a semaglutide prescription if appropriate, and have medication delivered to their home. A physician consultation and medical evaluation are required before any prescription is issued. In-person visits are not required in most U.S. states.

What is the difference between Wegovy and Ozempic?

Both Wegovy and Ozempic contain semaglutide, but they are approved for different indications. Ozempic (up to 2 mg weekly) is FDA-approved for type 2 diabetes management. Wegovy (up to 2.4 mg weekly) is FDA-approved for chronic weight management. The higher dose in Wegovy is what produces the greater weight loss outcomes seen in the STEP trials.

How long does a semaglutide program last?

Semaglutide is typically used as a long-term treatment. Clinical data shows that patients who discontinue semaglutide often regain significant weight within 12 months. Many physicians recommend ongoing treatment as part of a chronic disease management strategy. The dose escalation phase typically takes 16 to 20 weeks to reach the maintenance dose.

Who qualifies for a semaglutide weight loss program?

Semaglutide (Wegovy) is FDA-approved for adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol. It is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2. A physician will evaluate your full medical history to determine eligibility.

Should I choose semaglutide or tirzepatide?

Tirzepatide has demonstrated greater average weight loss in clinical trials (~20-22% vs ~15% with semaglutide). Semaglutide has a longer track record and established cardiovascular benefit data from the SELECT trial. The right choice depends on your health history, cardiovascular risk, goals, tolerability, and budget. A board-certified physician is best positioned to make this recommendation.

Medical Disclaimer: The information provided on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Semaglutide is a prescription medication that requires evaluation and oversight by a licensed physician. Clinical trial results represent averages and individual outcomes vary significantly. Always consult a qualified healthcare provider before starting any medication or weight loss program. DietsMD physicians are licensed in applicable states and follow all applicable telehealth regulations.
Visa Mastercard American Express JCB PayPal Apple Pay Google Pay